Table 1.
Patient characteristics
| 90Y-DOTATATE (n = 25) | 90Y/177Lu-DOTATATE (n = 25) | |
|---|---|---|
| Age range | 37–75 | 31–73 |
| Mean ± SD | 57.3 ± 10.6 | 55 ± 11.5 |
| Sex: female | 14 (56%) | 16 (64%) |
| Female age range | 37–75 | 39–73 |
| Mean ± SD | 58.2 ± 2.9 | 58.5 ± 12.4 |
| Male age range | 37–70 | 39–64 |
| Mean ± SD | 54.3 ± 10.8 | 53.7 ± 9.3 |
| Foregut | 12 (48%) | 13 (52%) |
| Midgut | 11 (44%) | 8 (32%) |
| Hindgut | 1 (4%) | 1 (4%) |
| MEN 1 | 0 | 1 (4%) |
| von Hippel-Lindau syndrome | 0 | 1 (4%) |
| Without primary | 1 (4%) | 1 (4%) |
| Size of lesion (CT in mm), range | 10–166 | 16–155 |
| Median (25%, 75%) | 50 (39, 91) | 47 (30, 75) |
| Number of lesions | ||
| 1 | 2 (8%) | 0 |
| 1–10 | 9 (36%) | 8 (32%) |
| >10 | 14 (56%) | 17 (68%) |
| Site of metastases | ||
| Liver | 19 (76%) | 20 (80%) |
| Bones | 4 (16%) | 7 (28%) |
| Lymph node | 10 (40%) | 7 (28%) |
| CgA (U/l ) | ||
| Range | 5.1–11,477 | 24–4,572 |
| Median (25%, 75%) | 423 (272.6, 1,000) | 179 (71, 417.8) |
| Surgery | 20 | 19 |
| Chemotherapy | 8 | 12 |
| “Cold” somatostatin analogues | 9 | 6 |